Kinney Drugs Foundation has announced a $250,000 pledge to the Crouse Health Foundation’s CrouseCares Campaign in support of the renovation and expansion of the Baker Regional Neonatal Intensive Care Unit (NICU) at Crouse Health. “The mission of Kinney Drugs is to help people live healthier lives through health and wellness initiatives,” said Dave McClure, President…
The Crouse Health Foundation is pleased to be a SADA Charity Preview beneficiary. Held on Wednesday, February 14 in conjunction with the Syracuse Auto Dealers Association Auto Expo at The Oncenter, guests will enjoy delicious food, drinks and musical entertainment as they mingle among the latest vehicle models. Crouse Health Foundation supports Crouse Hospital in…
In an ongoing effort to assist prospective parents in finding hospitals that deliver quality, affordable maternity care, Excellus BlueCross BlueShield has announced that Crouse Health has been once again designated as a Blue Distinction Center+ for Maternity Care. Crouse is the only Syracuse hospital to receive the Center+ distinction and was one of the first…
Crouse Health is the first hospital in Central New York to use the Watchman device, a minimally invasive implant approved by the U.S. Food and Drug Administration as an alternative to long-term blood thinner therapy for patients with atrial fibrillation (AFib), a common heart rhythm disorder. Studies have shown that the Watchman device offers patients…
